STOCK TITAN
  1. Home
  2. NRNVF

NORDIC NANOVECTO (NRNVF) Stock Price, News & Analysis

NRNVF OTC

Company Description

NORDIC NANOVECTO (OTC: NRNVF) is classified in the pharmaceuticals: other industry within the Health Technology sector.

This page collects what Stock Titan holds for NRNVF, including price data, latest news, SEC filings, insider trading activity, financial highlights, upcoming events, and short interest trends.

Stock Performance

Chart
$—
-
-
Last updated:
-
Performance 1 year
-
Market Cap
-
Shares outstanding

Latest News

View All
—

Nordic Nanovector Announces Initial Results from LYMRIT 37-05 Phase 1 Trial of Betalutin® in Relapsed/Refractory Diffuse Large B-cell Lymphoma (DLBCL)

clinical trial
—

Nordic Nanovector ASA: Allocation of restricted stock units (RSUs) to the board of directors

—

Nordic Nanovector ASA: Results for the First Quarter 2021

earnings
—

Nordic Nanovector Announces Update from Archer-1 Phase 1b Trial of Betalutin® in combination with rituximab in 2L Follicular Lymphoma

clinical trial
—

Nordic Nanovector ASA: Invitation to First Quarter 2021 Results Presentation and Webcast

earnings
—

Nordic Nanovector ASA publishes 2020 Annual Report

NORDIC NANOVECTO has 8 recent news articles. Key topics include clinical trial, earnings. View all NRNVF news →

SEC Filings

View All

No SEC filings available for NRNVF.

Financial Highlights

—
Revenue (latest FY)
—
Net Income (latest FY)
—
Diluted EPS (latest FY)
—
Operating Cash Flow
—
Net Profit Margin
—
Oper. Profit Margin

Upcoming Events

Short Interest History

Last 12 Months

Days to Cover History

Last 12 Months

NRNVF Company Profile & Sector Positioning

NORDIC NANOVECTO (NRNVF) operates in the Pharmaceuticals: Other industry within the broader Health Technology sector and is listed on the OTC.